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We isolated a novel strain of tickborne encephalitis 
virus (TBEV), Glubinnoe/2004, from a patient with a fatal 
case in Russia. We sequenced the strain, whose landmark 
features included 57 amino acid substitutions and 5 modi-
ﬁ  ed cleavage sites. Phylogenetically, Glubinnoe/2004 is a 
novel variant that belongs to the Eastern type of TBEV.
T
ickborne encephalitis virus (TBEV) was originally iso-
lated in the Far Eastern region of Russia in 1937 (1). 
TBEV is deﬁ  ned as a species within the Mammalian tick-
borne virus group (genus Flavivirus, family Flaviviridae) 
(2). The TBEV species includes 3 subtypes, Far Eastern 
(previously RSSE), Siberian (previously West-Siberian), 
and Western European (previously Central European en-
cephalitis [CEE]) viruses. Recently, taxonomic improve-
ments were proposed, and TBEV were divided into 4 types: 
Western, Eastern, Turkish sheep, and Louping ill (3). 
TBEV has been found in nearly 30 countries in Europe and 
Asia (4), and ≈700 million persons live in areas (excluding 
the People’s Republic of China) where TBEV infection is 
endemic. The annual incidence of TBEV infection is esti-
mated to be as many as 14,000 cases (5). Eleven thousand 
TBE cases occur annually in Russia, but only ≈150 cases 
are registered in Primorsky District, Russia (6). The Far 
Eastern subtype is considered to be the most pathogenic for 
humans, with a mortality rate of >20%. The Western Eu-
ropean subtype is less virulent and lethal (7,8). The TBEV 
genome consists of a single-stranded, positive-sense RNA 
of ≈11,000 nt that encodes 3 structural and 7 nonstructural 
proteins (9). The differences in nucleotide sequences en-
coding protein E between subtypes of TBEV may reach 
18%–19%; amino acid sequences are considerably more 
conserved (10). In 2004, a total of 76 conﬁ  rmed TBE cases 
occurred in the spring-summer season in Primorsky Dis-
trict; 10 were fatal. We describe 1 case caused by a novel 
variant of TBEV.
The Patient
A 15-year-old boy received 2 tick bites near the village 
of Glubinnoe, in the northern part of Primorsky District, on 
May 30 and June 1, 2004, respectively. He had not had any 
vaccinations against TBEV infection. The ﬁ  rst prodromal 
symptoms developed on June 8. A high fever with strong 
headache and paresis of cervical muscles developed in the 
next 2 days. On June 11, the patient was transported by 
emergency airplane from a local hospital to the Regional 
Clinical Hospital No. 1 in Vladivostok, where high fever 
with pronounced meningeal symptoms and complete dis-
orientation in place and time were observed. Coma and 
acute respiratory dysfunction due to paralysis of respiratory 
muscles developed the next day, and the patient was put 
on an automatic respirator. He died of acute cardiovascular 
insufﬁ  ciency and heart failure on June 17.
Virus strain Glubinnoe/2004 was isolated from a brain 
sample from the patient by using pig kidney embryo (PKE) 
cells. One hundred microliters homogenized brain diluted 
1:100 was applied onto PKE cells in minimal essential 
medium supplemented with 2% fetal calf serum. The cells 
were incubated at 37°C for 4 days, and cell culture superna-
tants were used for second passage on PKE cells. The virus 
for sequencing and immunologic experiments was puriﬁ  ed 
from infected PKE cells on third passage by centrifugation 
on a sucrose gradient (11). The protocol of study was ap-
proved by the Institutional Review Board of the Institute of 
Epidemiology and Microbiology, Vladivostok. Handling 
of the infectious material was performed under Biosafety 
Level 3–4 conditions.
A panel of monoclonal antibodies (MAbs) to TBEV 
was used for ELISA as described earlier (12). Viral RNA 
was extracted by using a RIBO-sorb kit (InterLabSer-
vice Inc., Moscow, Russia); then RNA was transcribed to 
cDNA and ampliﬁ  ed by PCR. The puriﬁ  ed cDNA frag-
ment was used for sequencing in a Beckman CEQ2000XL 
sequencer (Beckman Coulter, Inc., Fullerton, CA, USA). 
Fifty primers were designed on the basis of the TBEV se-
quence (GenBank DQ989336), allowing ≈150-bp overlap 
between adjacent PCR fragments. Each PCR fragment was 
independently ampliﬁ   ed and sequenced 3×. Sequences 
were aligned with ClustalX (13). Molecular data were sta-
tistically processed by using the program MEGA (14). The 
program PHYLIP version 3.57 (University of Washington, 
Seattle, WA, USA) or PUZZLE version 4.0.2 (University 
of Munich, Munich, Germany) was used for constructing a 
phylogenetic tree.
The nucleotide sequences of the viral isolates were 
compared with published complete polyprotein sequenc-
es of TBEV (Table 1). The complete coding sequence of 
Glubinnoe/2004 was 10,886 nt. We found profound dif-
ferences in the nucleotide sequences between listed TBEV 
strains and the Glubinnoe/2004 strain. The identity with 2 
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typical Far Eastern strains, 205 and Sofjin-HO, was 95.2% 
and 94.9%, respectively (Table 1). The complete Glubin-
noe/2004 nucleotide sequence was compared with other 
TBEV sequences available in GenBank. The conservation 
of the strain’s nucleotide sequences ranged from 82.7% 
to 95.2%, whereas amino acid sequences’ conservation 
ranged from 91.0% to 98.4%, depending on the type of 
TBEV (Table 1). To further delineate the genetic variation, 
we analyzed polyprotein sequences of 37 other ﬂ  aviviruses 
in comparison with Glubinnoe/2004 (Table 2). Fifty-three 
and 57 amino acid (aa) substitutions were found when Glu-
binnoe/2004 was compared to strains 205 and Sofjin-HO, 
respectively, and 14 of these were unique substitutions for 
all studied ﬂ  aviviruses. Most substitutions were located in 
the C-terminal hydrophobic domain (CTHD) of proteins 
C, NS3, and NS5. The CTHD had 5 substitutions in 20 aa 
fragment; NS3, 10 substitutions, and NS5,16 substitutions. 
We also found that 5 putative cleavage sites of polyprotein 
were modiﬁ  ed; the changes were located in viral C/CTHD 
and anchored C/prM sites. No substitutions were found in 
well-known features of protein E, such as the 12 cysteine 
residues, potential N-glycosylation sites, fusion peptide, 
and DEXH core motif of the NS3 helicase. A cysteine 
residue in position 4 of NS1 protein was replaced with a 
glycine; this mutation was described previously only for 
Sofjin-HO (BAB72162).
We also performed phylogenetic analysis of the fully 
sequenced TBEV strains and Glubinnoe/2004 (Figure 1) 
and analyzed 100 different protein E gene sequences avail-
able in GenBank (data not shown). Both phylogenetic trees 
clearly demonstrated that Glubinnoe/2004 belonged to the 
Eastern type and formed a separate clade (branch or group) 
within the type. The time of divergence of Glubinnoe/2004 
from the Oshima-Sofjin and Senzhang groups was calcu-
lated by using the average substitution rate analysis (15). 
We estimate that Glubinnoe/2004 and Senzhang group 
diverged 300–470 years ago and Glubinnoe/2004 and Os-
hima-Sofjin group, 320–490 years ago. Our ﬁ  ndings sug-
gest that parallel evolution of different genetic groups of 
TBEV occurred in the relatively small Far Eastern region 
of Russia.
The growth curves for Glubinnoe/2004 and 205 
viruses in PKE cells at 37°C are shown in Figure 2. The 
virus yield rapidly increased 9–18 h after infection and 
then stabilized. The maximum difference in virus yields (in 
50% tissue culture infective doses [TCID50]/mL) between 
Glubinnoe/2004 and 205 viruses was 2.1 TCID50/mL at 
12 h postinfection and nearly 10× from 15 to 36 h. By 
72 h postinfection, PKE cells infected by Glubinnoe/2004 
and 205 were completely lysed. We also evaluated the rep-
lication of viruses by directly measuring viral E protein 
levels by using 2 MAbs. E protein level rapidly increased 
15–24 h postinfection and was similar for both strains. This 
ﬁ  nding correlated with a production rate of infectious vi-
rions with delay close to 6 h, which demonstrates that the 
Glubinnoe/2004 strain may produce more infectious virions 
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Table 1. Tickborne encephalitis virus (TBEV) strains used in the study and comparison of identify for full-length polyprotein sequences
with strains Glubinnoe/2004 of TBEV* 
Glubinnoe/2004
Virus, subtype, strain  Place of origin 
Year of 
isolation
% Identity  
of nt sequence 
% Identity  
of aa sequence 
TBEV, Eastern type 
Glubinnoe/2004 Glubinnoe, Primorsky district, Russia  2004 100.0 100.0
205 Khabarovsk district, Russia  1973 95.2 98.4
Sofjin-HO  Khabarovsk district, Russia  1937 94.9 98.3
Oshima 5–10  Oshima, Japan  1995 94.7 98.2
Senzhang China 1953 94.8 98.4
MDJ-01 China 2003† 94.6 98.0
Vasilchenko Novosibirsk, Russia 1969 85.9 94.9
Zausaev Tomsk, Russia 1985‡ 85.9 94.9
EK-328 Estonia 1972 85.7 94.9
TBEV, Western type 
Neudoerfl Neudoerfl, Austria 1971 84.3 93.4
263 Temelin, Czech Republic  1987 84.5 93.3
Hypr  Brno, Czech Republic  1953 84.1 93.0
TBEV, Turkish sheep type 
Turkish sheep encephalitis  Turkey  1969 82.9 91.0
TBEV, Louping ill type 
Louping ill, strain 369/T2  Selkirkshire, Scotland  1929 83.2 91.0
Spanish sheep encephalitis  Spain 1987 82.7 91.0
*TBEV type classification described previously (3). nt, nucleotide; aa, amino acid. 
†Time of submission of the sequence to GenBank. 
‡Virus was isolated from a patient with chronic form of TBEV infection; a patient was infected in 1973 in Tomsk; the virus was isolated in Moscow in 1985 
from brain. DISPATCHES
in the early stage of infection of a PKE cell. The discovered 
mutations in 4 of 5 cleavage sites in viral polyprotein are 
required for cleavage of structural viral proteins. This ﬁ  nd-
ing may explain the more robust formation of infectious 
virions in the early stages of infection.
Serologic data demonstrate that strain Glubinnoe/2004 
has epitopes well recognized by 14 anti-TBEV MAbs (data 
not shown). Based on these data, we concluded that all 
protein E epitopes of strain 205 virus are also present on 
Glubinnoe/2004 virions and are not affected by 4 aa substi-
tutions found in protein E. This would suggest that modern 
vaccines against TBE and diagnostic immunologic kits will 
be effective against this novel variant.
Conclusions
We have genetically characterized TBEV isolate Glu-
binnoe/2004 by determining its complete coding nucleotide 
sequence and comparing it with most of the available TBEV 
sequences. We found 53 and 57 aa substitutions in compari-
son with strains 205 and Sofjin-HO, respectively, and 14 
of these were unique for 37 ﬂ  aviviruses. Most substitutions 
were located in the CTHD of proteins C, NS3, and NS5. 
Phylogenetic analysis showed that Glubinnoe/2004 appears 
to be a separate lineage within the Eastern type of TBEV. 
We estimate that strain Glubinnoe/2004 diverged from East-
ern TBEV in Senzhang group ≈300–470 years ago and from 
viruses in the Oshima-Sofjin group ≈320–490 years ago.
1576  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 10, October 2007
Table 2. Individual amino acid substitutions of Glubinnoe/2004 and 205/Sofjin-HO viruses and unique substitutions in comparison with 
37 flaviviruses, determined by polyprotein alignment*† 
Amino acid substitutions Glubinnoe/2004 → 205  
or Sofjin-HO 
Gene 205 Sofjin-HO
Unique
substitutions
Changed putative 
cleavage sites
Summary of 
substitutions
205/Sofjin-HO
Viral C  No M43 → L; A54 → V; 
N64 → K 
No No 0/3
CTHD A99‡ → V; I108 → V;  
M111 → I; M113‡ → V; 
F115‡ → L 
A99‡ → V; I108 → V;  
M111 → L; M113‡ → V;
F115‡ → L 
No Viral C/CTHD
(RGKRR/SAA†DW) 
anchored C/prM 
(GM‡TF‡A/ATVRK) 
5/5
prM No No No No 0/0
MR 210‡ → P  R210‡→ P; I246 → M; 
I266→ V 
R210* prM/M (SRTRR/SVLIR‡)  1/3
EK 508 → R; I597 → T; 
T646 → N; V743 → A 
A433 → V; T646 → N; 
M740 → V; G759 → S 
No No 4/4
NS1 G780‡ → C; K883 → R; 
S951 → P; I1053 → T 
I1053 → T; V1122 → I  No E/NS1
(LGVGA/DVGG‡A) 
4/2
NS2A R1180 → K; R1227 → S; 
G1250 → S; G1277 → E; 
C1311 → Y 
R1180 → K; R1227 → S; 
G1250 → S; G1277 → E; 
I1296 → T; A1297 → V 
No No 5/6
NS2B V1423 → M  V1423 → M  No No 1/1
NS3 E1563 → D; G1650 → E; 
I1673 → S; I1707 → T; 
T1828 → S; A1861 → V; 
P1948 → Q; V1975 → G; 
D1988 → N; A2062 → T 
D1491‡ → G; S1551 → Y; 
E1563 → D; G1650 → E; 
I1673 → T; N1731 → S; 
T1828 → S; T1869 → A; 
P1948 → Q; V1975 → G; 
D1988 → N; A2062 → T 
E1563;
G1650;
P1948;
V1975;
D1988
NS2B/NS3
(RTARR/SD‡LVF)
10/12
NS4A D2143 → E ;V2165 → A  D2143 → E; A2173 → G  D2143 No 2/2
NS4B M2283 → L; I2314 → M; 
A2331 → V; V2349 → I; 
A2472 → V 
M2283 → V; F2347 → L; 
S2457 → A 
M2283 No 5/3
NS5 K2625 → R; A2757 → G; 
G2758 → D; E3013 → G; 
S3014 → F; G3033 → E; 
K3074 → R; V3080 → I; 
S3187 → G; P3251 → R; 
V3260 → I; I3297 → V; 
V3342 → I; K3389 → E; 
Y3402 → D; N3406 → E 
K2526 → R; M2641 → V; 
A2757 → G; G2758 → D; 
E3013 → G; Y3030 → H; 
V3080 → I; R3188 → G; 
P3251 → R; I3297 → V; 
V3342 → I; V3343 → A; 
R3384 → K; K3389 → E; 
Y3402 → D; N3406 → E 
A2757;
G2758;
P3251;
K3389;
Y3402;
N3406
No 16/16
Total 14 5 53/57
*Position number corresponds to the polyprotein sequence Glubinnoe/2004 of tickborne encephalitis virus (TBEV). CTHD, C-terminal hydrophobic 
domain.
†The following polyprotein sequences were used for polyprotein alignment: DQ862460 (TBEV, Glubinnoe/2004); ABJ74160 AAN73266 BAB71943  
BAB72162 AF 069066 AAD34205 ABF46836 AAO43537 NP_043135 Neudoerfl AAZ80455 AAA86739 (TBEV, 263); Q01299 Hypr ABB90676 BB90675 
AAQ91606 Bogolubovka NP 878909 Bogoluvovska AAR98531 Kubrin ABB90677 NP_044677 NP_620108 AAF75260E5 P29837 (AAQ91607 
NP_722551 NP_620099 AAL32169 ABB90669 ABB90671 YP_224133 ABE73208 ABB90673 ABB90670 ABB90674 ABB90668 ABB90672 NP_689391). 
‡For substitution in cleavage sites. Novel Variant of Tickborne Encephalitis Virus
Five putative cleavage sites of the viral polyprotein 
were changed, including 4 sites responsible for process-
ing of structural proteins. Strain Glubinnoe/2004 replicated 
more effectively in PKE cells than did strain 205. These 
data suggest that Glubinnoe/2004 could be used for pro-
duction of vaccines, instead of strains 205 and Sofjin, and 
for development of diagnostic kits. This conclusion is sup-
ported by immunologic data with anti-TBEV MAbs, which 
demonstrated that viral glycoprotein E has a conserved an-
tigenic structure typical of the Eastern type of TBEV.
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